Abstract
Sulfasalazine (SASP) has been used for many years as a disease-modifying agent in inflammatory bowel disease and in rheumatoid arthritis. However, its mode of action is not entirely clear. Evidence has been accumulated which indicates that its efficacy is due to an immunomodulatory effect. In the present communication, we report that SASP has an immunomodulatory capacity in an experimental rat cardiac allograft model. A combination of 100 mg/kg per day of SASP given orally until rejection and 10 mg/kg per day of cyclosporine A (CyA) given orally for 10 days resulted in a significantly increased graft survival time as compared to that in animals given CyA alone.
This is a preview of subscription content, log in via an institution to check access.
Refereneces
Ali ATMM, Basran GS, Morley J (1982) Mode of action of sulphasalazine: an alternative view. Lancet I: 506–507
Bach MK, Brashler JR, Johnson MA (1985) Inhibition by sulphasalazine on LTC syntetase and of rat liver glutathione S-transferases. Biochem Pharmacol 34: 2695–2704
Carlin G, Djursäter R, Smedegård G, Gerdin B (1985) Effect of anti-inflammatory drugs on xanthine oxidase and xanthine oxidase induced depolymerization of hyaluronic acid. Agents Actions 16: 377–384
Gibson PR, Jewell DP (1985) Sulphasalazine and derivatives, natural killer activity and ulcerative colitis. Clin Sci 69: 177–184
Grisham MB, Ryan E, Ritter C von (1987) 5-aminosalicylic acid scavenges hydroxyl radical and inhibits myeloperoxidase activity. Gastroenterology 92: 1416
Hall BM, Jelbart ME, Dorsch SE (1984) Suppressor T cells in rats with prolonged cardiac allograft survival after treatment with cyclosporine. Transplantation 37: 595–600
Holmdahl R, Klareskog L, Rubin K, Björk J, Smedegård G, Jonsson R, Andersson M (1987) Role of T lymphocytes in murine collagen induced arthritis. Agents Actions 19: 295–305
Hoult JRS (1986) Pharmacological and biochemical actions of sulphasalazine. Drugs [Suppl 1] 32: 18–26
Hoult JRS, Moore PK (1978) Sulphasalazine is a potent inhibitor of prostaglandin 15-hydroxydehydrogenase: possible basis for therapeutic action in ulcerative colitis. Br J Pharmacol 64: 6–8
Neal TM, Winterbourn CC, Vissers MC (1987) Inhibition of neutrophil degranulation and superoxide production by sulphasalazine. Biochem Pharmacol 36: 2765–2768
Olausson M, Mjörnstedt L, Lindholm L, Brynger H (1984) Non-suture grafting to the neck vessels in rats. Acta Chir Scand 150: 463–467
Svartz N (1942) Salazopyrine, a new sulphanilamide preparation. Acta Med Scand 110: 577–598
Author information
Authors and Affiliations
About this article
Cite this article
Wanders, A., Tufveson, G. & Gerdin, B. The enhancing effect of cyclosporine A and sulfasalazine on the prevention of rejection in rat cardiac allografts. Transplant Int 1, 113–115 (1988). https://doi.org/10.1007/BF00353831
Issue Date:
DOI: https://doi.org/10.1007/BF00353831